Gynoflor 1×108 CFU, 0,03 mg Vaginal Tablet
Clinical Summary
Quick overview from the medicine insert
Indication
Atrophic vaginitis and symptomatic vaginal atrophy due to oestrogen deficiency.
Dosage (summary)
1 vaginal tablet daily for at least 12 days, then 1 tablet 2-3 times per week.
Onset of Action / Duration
Onset: 6-12 days, Duration: Not specified
Special Populations
- Elderly patients
- Renal insufficiency
- Hepatic insufficiency
Pregnancy & Breastfeeding
May be used during pregnancy after risk assessment; safe during lactation.
Key Drug Interactions
- Anti-infective medicines may reduce efficacy
Contraindications
- Hypersensitivity to active substances
- Breast cancer
- Oestrogen-dependent tumors
- Endometriosis
- Unexplained genital bleeding
- Severe venous thromboembolic disease
- Severe hepatic insufficiency
- Girls before menarche
Common side effects
- Vulvovaginal burning sensation
- Vulvovaginal pruritus
- Vaginitis
Counselling Points
- Insert tablet deeply in the evening
- Report any unexpected bleeding or breast changes
- Use alternative contraception during treatment
Serious warnings
- Monitor for abnormal vaginal bleeding
- Careful assessment of risks and benefits annually
- Discontinue if jaundice or liver function worsens
The Gynoflor 1×108 CFU, 0,03 mg Vaginal Tablet professional information leaflet below is the property of Adcock Ingram and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.